ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,378Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 1006

$1.74M Total Retail Price of All Prescriptions

Rank: 8 out of 1006

881 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 881 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 881 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 21,375 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 1,119 1,004 1 6
WARFARIN SODIUM 974 930 2 8
LEVOTHYROXINE SODIUM 861 671 3 2
SIMVASTATIN 766 611 4 1
METOPROLOL TARTRATE 677 605 5 7
AMLODIPINE BESYLATE 660 579 6 4
LISINOPRIL 582 517 7 3
ATORVASTATIN CALCIUM 538 474 8 5
DONEPEZIL HCL 457 438 9 17
MIRTAZAPINE 422 412 10 26
TRAZODONE HCL 405 355 11 21
OMEPRAZOLE 390 327 12 9
METOPROLOL SUCCINATE 347 315 13 12
METFORMIN HCL 340 249 14 10
ESCITALOPRAM OXALATE 327 288 15 27
GABAPENTIN 325 245 16 20
POTASSIUM CHLORIDE 296 284 17 30
HYDROCODONE-ACETAMINOPHEN 290 137 S3 18 25
SERTRALINE HCL 284 252 19 19
ZOLPIDEM TARTRATE 279 204 20 14
PREDNISONE 275 223 21 33
NAMENDA 262 253 22 34
NEXIUM 256 164 23 28
TAMSULOSIN HCL 242 211 24 23
RISPERIDONE 238 233 25 40
CITALOPRAM HBR 224 158 26 24
LANTUS 199 185 27 43
ATENOLOL 195 175 28 13
ISOSORBIDE MONONITRATE ER 190 184 29 59
HYDROCHLOROTHIAZIDE 189 168 30 11
ADVAIR DISKUS 188 153 31 37
CYMBALTA 185 136 32 41
CARVEDILOL 180 150 33 36
TRAMADOL HCL 170 65 34 35
GLIMEPIRIDE 168 132 35 50
MECLIZINE HCL 158 97 36 137
PANTOPRAZOLE SODIUM 154 78 37 32
PLAVIX 151 145 38 61
CLOPIDOGREL 149 138 39 46
SPIRIVA 148 141 40 48
ALLOPURINOL 146 143 41 31
SPIRONOLACTONE 144 130 42 71
CRESTOR 140 118 43 18
OXYCODONE-ACETAMINOPHEN 138 56 S2 44 57
CARBIDOPA-LEVODOPA 138 137 44 80
LIDODERM 135 115 46 66
SINGULAIR 134 91 47 82
KLOR-CON M20 132 116 48 70
QUETIAPINE FUMARATE 123 109 49 45
LABETALOL HCL 118 112 50 164
LIPITOR 114 94 51 47
LEXAPRO 113 104 52 103
OXYCODONE HCL 113 72 S2 52 54
DIGOXIN 110 106 54 52
NOVOLOG 110 100 54 94
ALENDRONATE SODIUM 108 105 56 29
FENTANYL 106 65 S2 57 74
CIPROFLOXACIN HCL 105 82 58 75
IBUPROFEN 103 41 59 114
OLANZAPINE 102 94 60 68
EXELON 101 101 61 99
GLIPIZIDE 98 86 62 69
PROAIR HFA 95 41 63 64
METOCLOPRAMIDE HCL 95 47 63 134
LEVEMIR 92 71 65 195
PRAVASTATIN SODIUM 92 87 65 15
CEPHALEXIN 91 72 67 142
ZETIA 91 86 67 51
DIOVAN 90 79 69 16
INSULIN SYRINGE 89 60 70 122
RANITIDINE HCL 89 74 70 63
CEFUROXIME 89 70 70 170
FINASTERIDE 89 76 70 76
BACLOFEN 87 41 74 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 61 75 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 85 73 76 118
DOXAZOSIN MESYLATE 84 72 77 87
CELEBREX 84 53 77 90
DETROL LA 83 45 79 219
JANUVIA 80 76 80 49
LACTULOSE 80 73 80 104
CARBAMAZEPINE 79 66 82 124
AMIODARONE HCL 78 77 83 168
LEVETIRACETAM 76 60 84 72
DICYCLOMINE HCL 74 35 85 297
TRAVATAN Z 73 73 86 131
METOLAZONE 72 63 87 210
FLUTICASONE PROPIONATE 72 45 87 55
MONTELUKAST SODIUM 72 45 87 125
QUINAPRIL HCL 72 70 87 86
VESICARE 71 71 91 163
PAROXETINE HCL 68 54 92 62
ALBUTEROL SULFATE 67 48 93 155
JANUMET 67 57 93 151
ACTOS 66 59 95 89
HYDROMORPHONE HCL 65 37 S2 96 153
AMITIZA 65 41 96 181
CYCLOBENZAPRINE HCL 63 30 R 98 113
CARISOPRODOL 63 0 R 98 172
CLOTRIMAZOLE-BETAMETHASONE 63 43 98 111
DIVALPROEX SODIUM 62 62 101 53
DILTIAZEM 24HR ER 62 38 101 126
OXYCONTIN 61 31 S2 103 98
VENLAFAXINE HCL ER 60 45 104 105
VERAPAMIL ER 60 56 104 116
NASONEX 60 39 104 176
SYNTHROID 59 59 107 42
AVODART 58 58 108 209
AMOXICILLIN 58 46 108 156
BENICAR 57 57 110 78
DIVALPROEX SODIUM ER 56 56 111 127
VYTORIN 56 46 111 145
NYSTATIN 55 27 113 191
ABILIFY 55 42 113 102
OXYBUTYNIN CHLORIDE ER 54 54 115 92
LANSOPRAZOLE 54 29 115 141
OXYCODONE HCL-ACETAMINOPHEN 53 29 S2 117 138
VENLAFAXINE HCL 53 41 117 249
DIOVAN HCT 51 44 119 60
METHOTREXATE 50 49 120 183
ACETAMINOPHEN-CODEINE 50 36 S3 120 139
CHLORHEXIDINE GLUCONATE 50 17 120 136
LUMIGAN 50 50 120 305
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 9, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.